Featured Speakers

Organizing Committee

David Ingbar, MD

David H. Ingbar, MD
Director, Pulmonary, Allergy & Critical Care Division
Co-Director of its Critical Care Fellowship Program
University of Minnesota School of Medicine
Minneapolis, Minnesota

Presentation Title
Barriers to Increasing Research in Critical Care

Dr Ingbar is currently Director of the Pulmonary, Allergy & Critical Care Division at the University of Minnesota School of Medicine (UMSM) and Co-Director of its Critical Care Fellowship Program. He is also Professor of Medicine and Pediatrics and Professor of Physiology at UMSM. Dr Ingbar is a Member of the Cancer Center at University of Minnesota, a Faculty Member of the Graduate Program in Integrative Physiology at the University of Minnesota Graduate School, and a Faculty Member of the MD/PhD Program, Biomedical Science Program, UMSM and Graduate School.

Dr Ingbar received his BA in Chemistry from Reed College and his MD from Harvard Medical School. He then completed a three-year Medical Residency in the Department of Internal Medicine, University of Washington, followed by a year as Chief Medical Resident. Dr Ingbar then spent three years as a Winchester Fellow in Pulmonary Medicine at the Yale University School of Medicine.

Prior to his current positions, Dr Ingbar was at Yale University School of Medicine as an Assistant Professor of Medicine in the Pulmonary and Critical Care Division, an Adjunct Assistant Professor of Cell Biology, and Associate Director of the Critical Care Fellowship Program. He was also Medical Director of Respiratory Therapy, Medical Director of the Medical Intensive Care Unit, and Medical Director of the Progressive Pulmonary Care (Stepdown) Unit at Yale New Haven Hospital.

Recipient of numerous honors and awards including the Best Doctors U.S. Award 2001-present, Dr Ingbar is currently President of the American Thoracic Society. A member of many professional organizations, Dr Ingbar has been a frequent Invited Speaker at several international and national conferences. His research interests include: repair of the damaged lung; cell biology of type I and II alveolar pneumocytes; resolution of pulmonary edema and lung ion transport; and cell biology of lung development, injury, and repair.

Dr Ingbar is presently working on three grants as Principal or Co-Investigator and has completed 21 other grants. A prolific writer, Dr Ingbar has 61 peer-reviewed scientific publications and 58 invited reviews, editorials, and chapters. He has 3 books edited, two manuscripts in preparation, and two case reports.